Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Transcriptome Sequencing of Peripheral Blood Mononuclear Cells from Elite Controller-Long Term Non Progressors.

Díez-Fuertes F, De La Torre-Tarazona HE, Calonge E, Pernas M, Alonso-Socas MDM, Capa L, García-Pérez J, Sakuntabhai A, Alcamí J.

Sci Rep. 2019 Oct 3;9(1):14265. doi: 10.1038/s41598-019-50642-x.

2.

Novel association of five HLA alleles with HIV-1 progression in Spanish long-term non progressor patients.

Ramírez de Arellano E, Díez-Fuertes F, Aguilar F, de la Torre Tarazona HE, Sánchez-Lara S, Lao Y, Vicario JL, García F, González-Garcia J, Pulido F, Gutierrez-Rodero F, Moreno S, Iribarren JA, Viciana P, Vilches C, Ramos M, Capa L, Alcamí J, Del Val M.

PLoS One. 2019 Aug 8;14(8):e0220459. doi: 10.1371/journal.pone.0220459. eCollection 2019.

3.

Association of a single nucleotide polymorphism in the ubxn6 gene with long-term non-progression phenotype in HIV-positive individuals.

Díez-Fuertes F, De La Torre-Tarazona HE, Calonge E, Pernas M, Bermejo M, García-Pérez J, Álvarez A, Capa L, García-García F, Saumoy M, Riera M, Boland-Auge A, López-Galíndez C, Lathrop M, Dopazo J, Sakuntabhai A, Alcamí J.

Clin Microbiol Infect. 2019 May 31. pii: S1198-743X(19)30274-5. doi: 10.1016/j.cmi.2019.05.015. [Epub ahead of print]

PMID:
31158522
4.

HLA-B*57 and IFNL4-related polymorphisms are associated with protection against HIV-1 disease progression in controllers.

Dominguez-Molina B, Tarancon-Diez L, Hua S, Abad-Molina C, Rodriguez-Gallego E, Machmach K, Vidal F, Tural C, Moreno S, Goñi JM, Ramírez de Arellano E, Del Val M, Gonzalez-Escribano MF, Del Romero J, Rodriguez C, Capa L, Viciana P, Alcamí J, Yu XG, Walker BD, Leal M, Lichterfeld M, Ruiz-Mateos E; ECRIS integrated in the Spanish AIDS Research Network.

Clin Infect Dis. 2017 Mar 1;64(5):621-628. Epub 2016 Dec 16.

5.

Hydroxytyrosol: a new class of microbicide displaying broad anti-HIV-1 activity.

Bedoya LM, Beltrán M, Obregón-Calderón P, García-Pérez J, de la Torre HE, González N, Pérez-Olmeda M, Auñón D, Capa L, Gómez-Acebo E, Alcamí J.

AIDS. 2016 Nov 28;30(18):2767-2776.

6.

Evolution of T-cell responses to hepatitis C virus (HCV) during pegylated interferon plus ribavirin treatment in HCV-monoinfected and in HCV/HIV-coinfected patients.

Capa L, Soriano V, García-Samaniego J, Nuñez M, Romero M, de Mendoza C, Cascajero A, Muñoz F, González-Lahoz J, Benito JM.

Antivir Ther. 2007;12(4):459-68.

PMID:
17668554
7.

Influence of HCV genotype and co-infection with human immunodeficiency virus on CD4(+) and CD8(+) T-cell responses to hepatitis C virus.

Capa L, Soriano V, García-Samaniego J, Nuñez M, Romero M, Cascajero A, Muñoz F, González-Lahoz J, Benito JM.

J Med Virol. 2007 May;79(5):503-10.

PMID:
17385690
8.

Immunological and virological effects of structured treatment interruptions following exposure to hydroxyurea plus didanosine.

Benito JM, López M, Ballesteros C, Lozano S, Capa L, Barreiro P, Sempere J, Gonzalez-Lahoz J, Soriano V.

AIDS Res Hum Retroviruses. 2006 Aug;22(8):734-43.

PMID:
16910828
9.

CD4+ T cell recovery beyond the first year of complete suppression of viral replication during highly active antiretroviral therapy is not influenced by CD8+ T cell activation.

Benito JM, Lopez M, Lozano S, Ballesteros C, Capa L, Martinez P, Gonzalez-Lahoz J, Soriano V.

J Infect Dis. 2005 Dec 15;192(12):2142-6.

PMID:
16288380
10.

Translation elongation factor 2 is encoded by a single essential gene in Candida albicans.

Mendoza A, Serramía MJ, Capa L, García-Bustos JF.

Gene. 1999 Mar 18;229(1-2):183-91.

PMID:
10095118
11.

Translation elongation factor 2 is part of the target for a new family of antifungals.

Capa L, Mendoza A, Lavandera JL, Gómez de las Heras F, García-Bustos JF.

Antimicrob Agents Chemother. 1998 Oct;42(10):2694-9.

Supplemental Content

Support Center